143 results
Page 4 of 8
8-K
EX-99.2
h0rkne07uvzyxc
7 Mar 22
Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
6:57am
8-K
4s39ub
7 Mar 22
Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
6:57am
8-K
EX-99.1
6mdh064c69
7 Mar 22
Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
6:57am
8-K
EX-99.3
9moglnc b9
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
8-K
EX-99.1
yy7lzjcy5t0
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
8-K
EX-99.2
w778xx4w chmw9ivtpn
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
8-K
wxzvo1ir 71
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
424B5
2k4yalq1kdkta6ss41
18 Nov 21
Prospectus supplement for primary offering
7:30am
8-K
EX-99.1
o3ra u0xxslud9zm
16 Nov 21
Other Events
8:04am
424B5
has0t3ouv488r
15 Nov 21
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
a7aocf1
15 Nov 21
Optinose Reports Third Quarter 2021 Financial Results
4:26pm
8-K
EX-99.01
8da5m9ptqf2uv
28 Oct 21
Other Events
7:00am
8-K
w1dbpep9gdenrr1e
28 Oct 21
Other Events
7:00am
8-K
EX-99.2
zbn yov36
11 Aug 21
Optinose Reports Second Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
rghvt63j
11 Aug 21
Optinose Reports Second Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
vgce2
30 Jul 21
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis
7:55am
8-K
stz5ss
30 Jul 21
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis
7:55am